Epigenetic inactivation of the hsa-miR-203 in haematological malignancies. - Wikidata - awgldk - TriplyDB

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

http://www.wikidata.org/entity/Q35216337

about

MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia Role of microRNA deregulation in the pathogenesis of diffuse large B-cell lymphoma (DLBCL)Therapeutic Resistance in Acute Myeloid Leukemia: The Role of Non-Coding RNAs miRNAs as Biomarkers in Chronic Myelogenous Leukemia Altered microRNA expression associated with chromosomal changes contributes to cervical carcinogenesis.High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq.Characterization of human gastric carcinoma-related methylation of 9 miR CpG islands and repression of their expressions in vitro and in vivo MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors Epigenetic Silencing of miR-203 Upregulates SNAI2 and Contributes to the Invasiveness of Malignant Breast Cancer Cells.Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms.Epigenetic inactivation of the MIR129-2 in hematological malignancies.Epigenetic silencing of tumor suppressor miR-3151 contributes to Chinese chronic lymphocytic leukemia by constitutive activation of MADD/ERK and PIK3R2/AKT signaling pathways.Mechanisms of epigenetic deregulation in lymphoid neoplasms.miR-203 facilitates tumor growth and metastasis by targeting fibroblast growth factor 2 in breast cancer Regulation of the unfolded protein response by microRNAs.MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.MicroRNAs as Haematopoiesis Regulators.Epigenetic inactivation of mir-34b/c in addition to mir-34a and DAPK1 in chronic lymphocytic leukemia.Epigenetic silencing of tumor suppressor long non-coding RNA BM742401 in chronic lymphocytic leukemia.DNA methylation of microRNA genes in multiple myeloma.Methylation of tumor suppressor microRNAs: lessons from lymphoid malignancies.DNA Methylation of Tumor Suppressive miRNAs in Non-Hodgkin's Lymphomas.Uncovering the DNA methylome in chronic lymphocytic leukemia.DNA methylation of tumor-suppressor miRNA genes in chronic lymphocytic leukemia.DNA methylation of tumor suppressor protein-coding and non-coding genes in multiple myeloma.A Macro View of MicroRNAs: The Discovery of MicroRNAs and Their Role in Hematopoiesis and Hematologic Disease.Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay.Infrequent DNA methylation of miR-9-1 and miR-9-3 in multiple myeloma.Epigenetic regulation of microRNA expression in Hodgkin lymphoma.MicroRNA epigenetic signatures in human disease.Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas.miRNAs in chronic myeloid leukemia: small molecules, essential function.Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.Downregulation of Potential Tumor Suppressor miR-203a by Promoter Methylation Contributes to the Invasiveness of Gastric Cardia Adenocarcinoma.Epigenetic silencing of miR-203 in Kazakh patients with esophageal squamous cell carcinoma by MassARRAY spectrometry.Epigenetic role of miRNAs in normal and leukemic hematopoiesis.Analysis of microRNA-203 function in CREB/MITF/RAB27a pathway: comparison between canine and human melanoma cells.Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas.MicroRNAs regulate key cell survival pathways and mediate chemosensitivity during progression of diffuse large B-cell lymphoma.

P2860

Q26766288-2C188E04-BE79-4FE2-8585-9A6E065301C0 Q27016561-BCD68F31-6FDE-450E-9485-117359029E42 Q28071427-6FB70DD6-098B-4CBE-8D6C-1DEE284586A3 Q28087081-21AD7405-98F1-4A03-9333-5B079FEA5C96 Q34254020-A91D104C-4A36-47C3-9545-18EDE2D6FA90 Q34254966-F8D750B2-A55D-4F3B-99E9-4E4A4BC8BEE6 Q34306332-A534A647-813C-439B-A8B2-9D6C218A6353 Q35103557-F81CD670-883C-48D5-B078-8A9AEE9001CA Q35755187-A24A53E7-74E4-4365-A20B-FC6C5BA88ACD Q35768988-105428FD-BAA6-4013-AF39-5C36EE9DD0FC Q36621405-1B3DED30-DF4B-4281-8961-ABD43739906B Q36688994-9CC0A461-3542-4229-8991-FC733974446D Q36873265-7501B4A6-8D58-4758-A87A-9E3BDB336057 Q37344496-EBBD4072-DBD1-439E-9B7F-4549AEBAFF4F Q37423378-0461905F-A90F-459A-9A48-B57597FDE6BD Q37437269-94C7E4FC-0CC5-4A66-AD55-708B87AE39AF Q37448597-052B294C-87F8-4ADD-8FAD-4A51080BD2DC Q37616347-C80F4CCB-BCD4-4007-8969-7A779F962A55 Q37696142-8AB52A19-D2A9-4D50-AA87-AA1F267E862E Q38020153-510780E1-AD97-4830-A450-A7F62834F711 Q38059899-3783B197-6EA8-4E00-9292-DEA0CC96ED67 Q38060723-5A6D6D3E-EDA9-4FBA-8B92-13014780B01E Q38074267-841991B3-163C-487F-9341-B8D5D66DA3BC Q38343779-F0E2110B-F33A-40E9-BCC2-6FBF04A55757 Q38595057-F83A2C65-C3CC-453C-90F0-120581EFEC14 Q38637596-8B37AB98-878F-4662-8A8B-4C45219240F8 Q38818836-9E3C4BA6-B8A8-4445-94D7-03205F8382FC Q38866390-B91EF9C4-DFAB-4232-BF1A-2032F3B2DEAF Q38889464-2E117AD6-53DB-44E7-AB27-7F86BD4DFD57 Q38920243-3DBDEAB3-6A18-40A3-9ED9-CA38F3D49171 Q38936390-89C0A21E-AF9E-4DC2-951F-8C2082AB3DB5 Q38957493-E379B915-D1F8-4A97-B7B9-66BBDFD6EF02 Q38979577-5A797B6B-6D20-4192-9ED5-83780723ADCB Q38996899-36A4DD96-D9F5-473D-8002-20BA9778AA77 Q40507688-B998697C-36B5-4051-B56F-6B6F37ACD4F0 Q44038911-1AF30DBC-C1AB-4DA2-9FED-0BC10A5899C2 Q46608275-31519A52-059A-4CF3-B5D2-32EAC34D9B3B Q46830544-A0B675A0-B6EC-4B07-9E13-BBC9EA8E3A24 Q47122404-52ADB682-7B94-4CBD-8833-FDD528E968D1 Q47292045-8F1E9748-1A85-4955-B076-F75CBA838539

P2860

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

http://www.wikidata.org/entity/Q35216337

description

2011 nî lūn-bûn

@nan

2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@ast

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@en

type

label

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@ast

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@en

prefLabel

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@ast

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.

@en

P1433

Q35216337-73185437-FBFF-4DD9-8712-54A24A6C26E1

P1476

Q35216337-0C17D941-02CD-4144-965B-B308C9CC9141

P2093

Q35216337-683DB430-3B7D-4704-9958-AAF9F8F6878D

Q35216337-700D9F88-93E7-4A6A-BC7A-A25BE23D279B

Q35216337-81F59329-6FBD-4C0A-995B-F8BC5F122E52

Q35216337-C4541D40-6700-486A-87B2-B090DEC66730

Q35216337-DFC2B2BE-7CBC-4817-AC66-DF07101581EA

P2860

Q35216337-1173BF64-4AEF-44AB-A668-3C7458E093B1

Q35216337-14682C9D-E9CD-45B0-91A3-93206E735B7B

Q35216337-224E4F32-1C70-43F0-8E05-D08C2C9DE232

Q35216337-2E861DE9-4A3A-4EF8-A627-2F358F0EA991

Q35216337-30ECD7E8-E98D-4B1B-979E-EC1E5D971798

Q35216337-3184A51A-5497-4105-94B2-348EDDB90D22

Q35216337-393C84E4-B6BA-4294-832C-607B6283940B

Q35216337-5CFE6135-31D1-4CBA-947E-093CE31A0DAB

Q35216337-66A7A2FE-037B-4718-B787-442BAB0C2ADC

Q35216337-75998FB5-8EFF-45F9-8776-21458289BD7E

P304

Q35216337-6C3A96FB-26C5-4A6A-B6B4-7288CB557F31

P31

Q35216337-CA386B3F-FCD2-43A7-93E1-F08488018BE6

P356

Q35216337-F4CB7F54-5CAA-4F09-BF0A-EC25024DA030

P433

Q35216337-454DAE12-AE8E-403F-B438-0E785C79F4FF

P478

Q35216337-35E65C08-97FE-4EA9-A942-9180D426478E

P50

Q35216337-03ED3BE6-F6AF-43C1-826C-281D8BA06092

Q35216337-95EE8C13-8E6E-42FD-97CA-2079DD319E46

P577

Q35216337-1AFC0532-8328-4B83-81CC-09FFCF552846

P5875

Q35216337-33D9745F-D167-4211-93CD-37734BBF5618

P698

Q35216337-6A645644-6939-4A48-AC54-B5D3A547938C

P932

Q35216337-363BCCAF-A475-491D-A598-9C898EF8FC73

P356

J.1582-4934.2011.01274.X

P1433

Journal of Cellular and Molecular Medicine

P1476

Epigenetic inactivation of the hsa-miR-203 in haematological malignancies

@en

P2093

Chung Ying Leung

http://www.w3.org/2001/XMLSchema#string

Lap Ping Chung

http://www.w3.org/2001/XMLSchema#string

Li Yu

http://www.w3.org/2001/XMLSchema#string

Pak Kwan Hui

http://www.w3.org/2001/XMLSchema#string

Sau Yan Chan

http://www.w3.org/2001/XMLSchema#string

P2860

Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Oncomirs - microRNAs with a role in cancer

Hypermethylation of gene promoters in hematological neoplasia

Epigenetic dysregulation of Wnt signaling pathway in multiple myeloma

Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression

Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group

Gene silencing in cancer in association with promoter hypermethylation

miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma.

Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas.

P304

2760-2767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1582-4934.2011.01274.X

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Kwan Yeung Wong

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49838562

http://www.w3.org/2001/XMLSchema#string

P698

21323860

http://www.w3.org/2001/XMLSchema#string

P932

4373446

http://www.w3.org/2001/XMLSchema#string